Anabolic Steroid • Injectable • Schedule III

DHB (1-Testosterone): A Potent Androgen With a Painful Reputation

📄 1 PubMed citation

Last updated: October 3, 2026

Dihydroboldenone (DHB, 1-testosterone) is the 5α-reduced analog of boldenone. In lab assays it bound selectively to the androgen receptor; in rats an equimolar dose matched testosterone propionate in androgenic and anabolic potency and increased liver weight (Friedel et al., Toxicol Lett 2006, PMID: 16621347). Human outcomes have not been studied clinically. Users commonly describe it as one of the most painful injectable steroids. This reference covers its pharmacology, practical considerations, and harm-reduction data.

Unstudied
Human Dosing
No Clinical Data
Not Expected to Aromatize
Estrogen Conversion
5α-Reduced Structure

How DHB Works

DHB is the 5α-reduced form of boldenone (EQ), structurally analogous to how DHT relates to testosterone.

🔬
5α-Reduction of Boldenone — Structural Basis

Boldenone (Equipoise) is the parent compound; DHB is its 5α-reduced metabolite, also called dihydroboldenone or 1-testosterone (not the same as testosterone despite the name). The 1,2-double bond distinguishes it from regular 5α-dihydrotestosterone.

💎
Not Expected to Aromatize

As a 5α-reduced steroid, DHB is not a substrate for aromatase, so it is not expected to convert to estradiol — a structural inference, since no study cited here measured estrogen in DHB users. Users describe a "dry" look, but water retention and bloating have not been measured clinically. Any co-administered testosterone will still aromatize normally.

💉
Post-Injection Pain (PIP) — The Major Practical Issue

Users widely report severe, prolonged post-injection pain, and commonly attribute it to DHB being hard to keep in solution (it can crash out of carrier oil); no cited study has measured its solubility or tested that cause. Mitigation strategies reported in community practice (untested): dilution with benzyl alcohol, MCT/GSO mix, warming the oil before injection, and lower concentrations. Higher concentrations are commonly reported as more painful.

🚫
Not 17α-Alkylated — Liver Effects Still Possible

Unlike Anadrol, Superdrol, or Dianabol, DHB is not 17α-alkylated and is typically used by injection. That does not make it liver-safe: in rats, 1-testosterone significantly increased liver weight, which testosterone propionate did not (Friedel et al., 2006). Its liver safety in humans has not been studied clinically.

What the Evidence Shows

DHB has minimal formal research. The one study cited on this page combined lab receptor assays with rat experiments (Friedel et al., 2006); human outcome data here is community-based and anecdotal (labeled).

Androgenic & Anabolic Potency (Rat)
Friedel et al. 2006 — an equimolar dose matched testosterone propionate on prostate, seminal vesicle and levator ani muscle growth
≈ Testosterone propionate
Dry Muscle Quality (Community Rating)
Anecdotal — users describe aesthetic quality as excellent
Highly rated
HPTA Suppression
Community reports — significant; not measured in a cited study
High (reported)
Liver Impact vs. Oral 17α-AA Steroids
No human data; in rats it increased liver weight, unlike testosterone propionate (Friedel et al. 2006)
Rat signal

Risks & Side Effects

Post-Injection Pain (PIP)
Community reports — severe and prolonged; not clinically studied
Severe (reported)
Androgenic Side Effects
Androgenic potency high in rats (equal to testosterone propionate, Friedel et al. 2006); side effects unrated in humans (acne, hair loss are community-reported)
Unrated in humans
HPTA Suppression
Community reports — significant suppression; not measured in a cited study
High (reported)
Hepatotoxicity
Non-17α-alkylated, but raised liver weight in rats; no human data
Unstudied in humans

Key Takeaways

✅ What We Know
  • 5α-reduced form of boldenone — structural analog to DHT/testosterone relationship
  • Not expected to aromatize (5α-reduced structure); the "dry" look is user-reported, not measured
  • In rats, as androgenic and anabolic as testosterone propionate, and it raised liver weight (Friedel et al., 2006)
  • Not 17α-alkylated, unlike oral steroids such as Anadrol
  • Users report PIP as the main practical problem, varying with concentration and formulation (community reports)
⚠️ Critical Risks
  • Users commonly report severe post-injection pain, sometimes lasting days (not clinically studied)
  • Very limited clinical research — safety profile largely anecdotal
  • Community reports describe significant HPTA suppression; no cited study measured it or tested post-cycle recovery
  • Higher-concentration formulations are commonly reported as more painful
  • Injection site abscesses possible if sterility is not maintained
📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.


Get the Guide — $19 (normally $29) →
New to peptides? Start with the $19 Buyer’s Playbook →
⚠️ Legal & Medical Disclaimer

This page is for educational and harm-reduction purposes only. Dihydroboldenone (DHB / 1-testosterone) is a Schedule III controlled substance under the Anabolic Steroid Control Act in the United States. It has not been approved by the FDA for any medical use. Unauthorized possession is illegal. This content does not constitute medical advice. Always consult a licensed physician before using any anabolic agent.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars — metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.